Company ProfilePremium

ageas SA/NV

Company Profile Analysis

Ticker: AGS.BR

ESOMAR 23 Corporate BadgeISO Certifications Badge
ageas SA/NV - Company showcase

Year Founded & Workforce

1824

53,000 Employees

ageas SA/NV logo

ageas SA/NV Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

ageas SA/NV Overview

Ageas is a Brussels-based international insurance group with roughly 200 years of heritage. It combines wholly owned European insurers with long-term bank and distributor partnerships in Asia. Since April 2026 it owns 100% of AG Insurance, Belgium's market leader, with about 28% Life and 17% Non-Life market share (Ageas corporate presentation, 8 Oct 2026). The September 2025 esure acquisition made it a top-three UK personal-lines insurer. It holds leading partnership positions in China (Taiping), India, Thailand, Vietnam and Türkiye, and has built Ageas Re into a fourth growth segment since 2023. Gross inflows reached EUR 19.6bn in FY2025 and Net Operating Result EUR 1.65bn (EUR 1.35bn excluding a one-off China tax benefit). Management has spent 2025–26 reshaping the portfolio: buying control in Belgium and scale in the UK, and exiting Malaysia at about 2x book. The aim is to raise the share of cash-generating, consolidated earnings under the Elevate27 plan (2025–27).


What the company does. Ageas is an insurance holding company. Through subsidiaries, joint ventures and associates, it underwrites Life insurance and Non-Life (property & casualty, health, accident) insurance, and has written third-party reinsurance since 2023. The Life side covers guaranteed savings, unit-linked investment products, protection, pensions and employee benefits. The group also manages large investment portfolios backing ~EUR 117bn of Life liabilities (H1 2026 press release). Through AG Insurance it owns AG Real Estate, a major Belgian property investor and developer.

Business model. The group runs a "hybrid" model:

  1. Consolidated, wholly owned operations in Belgium (AG Insurance, 100% since 28 Apr 2026), the UK (Ageas UK, esure, Acromas/AICL) and Portugal. These produce the bulk of the cash upstream to the holding.

  2. Non-consolidated partnerships — equity-accounted JVs and associates — with banks and conglomerates in China (China Taiping), India (Federal Bank, Sundaram Finance), Thailand (Muang Thai), Vietnam, the Philippines, Laos, Cambodia and Türkiye (Sabancı). Ageas contributes technical, actuarial and product know-how. The partners contribute distribution, chiefly bancassurance and agency networks.

  3. Ageas Re, launched for third-party business in 2023. It writes inward reinsurance and also centralises internal reinsurance, including a quota share programme on Belgian business (the 2025 Belgian combined ratio of 90.5% is quoted "before the quota share reinsurance programme" — Ageas corporate presentation, 8 Oct 2026).

Revenue model. As an insurer, Ageas does not sell products, services, subscriptions or licences in the industrial sense. Its economic revenue has three parts:

  • Insurance service revenue: premiums earned, recognised under IFRS 17 as the Contractual Service Margin (CSM) is released.

  • Investment income on the general account.

  • Fee margins on unit-linked and pension assets.

Gross inflows in FY2025 were EUR 19.6bn. On the FY2024 split, Life was EUR 11.7bn (~63%) and Non-Life EUR 6.8bn (~37%) (Ageas FY2024 press release). The CSM, the stock of unearned future Life profit, stood at EUR 11.1bn at H1 2026.

Value-chain position. Ageas sits in primary underwriting and risk carrying, and in asset-liability management. Distribution is largely outsourced or partnered:

  • Belgium: independent brokers (AG's broker channel) plus exclusive bancassurance with BNP Paribas Fortis, renewed for 15 years from 1 Jan 2027.

  • UK: brokers, price comparison websites (PCW), direct (esure), affinity (Saga, a 20-year agreement) and embedded partners (BYD, Wrisk).

  • Asia: bank branches and agents (Taiping Life: ~230,000 agents and access to ~70,000 bank branches).

Asset management is partly internal, and since 2026 partly through a long-term partnership between AG Insurance and BNP Paribas Asset Management.

Customer types and end-markets. The group serves:

  • Retail individuals (motor, home, savings, protection, health).

  • Older and retired customers (the "ageing" strategic focus and the Saga over-50s franchise).

  • SMEs (an Elevate27 growth priority).

  • Corporates and employers (group pensions and employee benefits in Belgium; Taiping Pension in China).

  • Cedents, i.e. other insurers buying reinsurance (Ageas Re).

Company self-description (paraphrased from FY2025 releases). Ageas describes itself as a Belgian-rooted, listed international insurance group with a 200-year heritage. It concentrates on Europe and Asia, which together make up most of the global insurance market, and ranks among the market leaders in each country where it operates. It serves retail and business customers in Life and Non-Life through wholly owned subsidiaries and long-term partnerships with strong financial institutions and distributors (Ageas boilerplate, press releases 2025–26).

Independent characterisation. Ageas is best seen as a Belgian life-and-P&C champion with a cash-generative core, attached to a portfolio of minority Asian growth options and a now-scaled UK personal-lines franchise. Its earnings mix is unusual among EU mid-cap insurers. Asia contributed EUR 860m of FY2025 NOR, about 48% of segment NOR before General Account costs, inflated by a EUR 300m one-off China deferred-tax benefit. Yet Asia remits relatively little cash: MAHB, for example, remitted EUR 21m against EUR 64m NOR in 2025. Management's 2025–26 actions — 100% of AG, esure, the Saga affinity deal, and selling Malaysia at about 2x book — shift the mix toward consolidated, remittable earnings. That supports the progressive dividend (DPS +6% p.a. targeted) while keeping a China growth anchor through Taiping. The main analytical tensions are three: the quality and fungibility of Asian earnings, the integration risk of esure, and the strategic implications of BNP Paribas's 24.1% stake.

Strategy

Elevate27 (2025–2027) — stated themes

Elevate27 succeeded Impact24 (2022–24) and Connect21 (2019–21). The company frames it around three strategic choices:

  1. profitable growth;

  2. technical insurance and operational excellence;

  3. distribution excellence and customer experience.

Sustainability is described as "at the core" (Ageas corporate presentation, 8 Oct 2026; Ageas sustainability page).

Named growth priorities: solutions for an ageing society (longevity, decumulation, health); SME; retail P&C; reinsurance; and a more locally driven Health & Protection approach. The group's diversification logic has three parts:

  • expand consolidated, cash-generating entities in Europe;

  • sustain a strong presence in growing Asian markets;

  • establish Reinsurance as an overarching business (CEO, FY2025 release).

Financial targets and evolution

Target (2025–27 cycle)At launch (Dec 2024)After H1 2025 (Aug 2025)Latest (Oct 2026)
Average NOR EPS growth (% p.a.)6–86–86–8
2027 EPS (EUR)——8.00–8.50, upper end expected
Holding Free Cash Flow, cumulative (EUR bn)>2.2>2.3>2.6
Shareholder remuneration, cumulative (EUR bn)—>2.0>2.2
DPS growth (% p.a.)666 (progressive)
Discounted combined ratio by 2027 (%)——~92, excluding exceptional weather
Additional Life & Pension liabilities from longevity initiatives by 2027 (EUR bn)——>2, on track to exceed
UK (esure) cost synergies (GBP M p.a.)>100 (Apr 2025)>100>130

Sources: H1 2025 press release; FY2025 press release; Quartr summaries of the 8 Oct 2026 investor update and corporate presentation.

EPS bridge (Investor update, Oct 2026): 4–6% from business growth, 2–3% from margin expansion and 0–1% from capital redeployment, summing to the 6–8% target range.

Initiatives announced in the last 24 months (Oct 2024 – Oct 2026)

InitiativeDateDescriptionTargets / status
Saga partnership + AICLOct–Dec 2024; AICL closed 202520-year exclusive motor/home affinity for over-50sGo-live targeted Q4 2025
esure acquisition and integrationApr 2025 – 2027Creates a top-3 UK personal-lines insurerROI >12%; HFCF/share ~10% accretive after 2027; full financial contribution from 2028
Full ownership of AG InsuranceDec 2025 – Apr 2026EUR 1.9bn; bancassurance renewed to 2041; asset management partnership with BNP Paribas AMAccretive to Elevate27 targets
Taiping Pension stakeMay 2024 – Mar 2026Entry into China's private pension marketOption to 24.99% within 3 years
Exit from MAHB (Malaysia)Aug–Sep 2026Value crystallisation at ~2x bookEUR 464m gain; proceeds "added to firepower" for Europe or Asia
Data & AI programme2025–26>300 use cases deployed; ~40 shareable group-wide; 35% claims/fraud, 20% underwriting, 20% CXOngoing
Nearly-retired / longevity programme2025–26Retain maturing Belgian Life liabilities>EUR 100m retained
UK embedded insurance (BYD, Wrisk)2025–26Point-of-sale motor insuranceLive
Ageas Federal Life digital distributionMay 2026Aggregator partnership3x premium by FY28 ambition

Sustainability commitments (Elevate27)

There are five non-financial KPIs: ESG ratings, sustainable products, customer cNPS, employee eNPS and gender diversity.

  • ESG rating target: top quartile with 3 of the 5 agencies the group engages with.

  • 2025 eNPS was 45.8 (top quartile).

  • 13 entities benchmark cNPS (Ageas newsroom, 2026).

Guidance

ItemGuidanceDate
FY2026 NOR>EUR 1.95bn, incl. ~EUR 450m MAHB gain, ~EUR 30m lost contribution, and an assumed ~3pp weather impact on the combined ratio27 Aug 2026
FY2026 cash upstream>EUR 1.4bn (+49%)27 Aug 2026
FY2026 interim DPSEUR 1.50, paid December 202627 Aug 2026

Products & Services

Pricing models for insurance products are risk-based premiums. Product-level pricing is not publicly disclosed and is therefore omitted from each entry.

Belgium — AG Insurance (100%)

Product line / brandDescription & capabilitiesTarget customerDistributionNotes
Guaranteed Life savings ("Branch 21")Capital-guaranteed savings with guaranteed rate plus profit sharing; underpins the Belgian Life guaranteed margin (102 bps in FY2025)Retail saversBrokers; BNP Paribas Fortis bank branchesCore of Belgian Life inflows; Belgian Life growth exceeded 10% in H1 2025
Unit-linked investment insurance ("Branch 23")Market-linked investment insurance; fee-based marginRetail and affluent investorsBancassurance, brokersAsset management partly via BNP Paribas AM from 2026
Group pensions & employee benefitsOccupational pensions, group life, disability, hospitalisationEmployers, corporates, SMEsBrokers, direct corporate salesAG is a market leader in Belgian employee benefits (per company positioning)
Health / hospitalisationIndividual and group medical expense coverEmployees, individualsBrokers, bancassurancePart of the "locally driven Health & Protection approach" (Elevate27)
Retail Non-LifeMotor, fire/home, family liability, legal assistanceHouseholdsBrokers, BNP Paribas FortisFY2025 Belgian Non-Life inflows +5%
SME / commercial Non-LifeProperty, liability, workers' compensationSMEsBrokersNamed Elevate27 growth priority
"Nearly-retired" / longevity solutionsRetention and decumulation propositions for maturing contracts55+ clientsBancassurance, brokers>EUR 100m of maturing liabilities retained via the programme (Investor update, 8 Oct 2026)
AG Real EstateReal-estate investment, development, property & car-park managementInstitutional (internal and third-party)DirectSupports the investment result

Europe — United Kingdom

Product line / brandDescriptionTarget customerChannelNotes
Ageas UK motorPrivate car insuranceRetailBrokers, affinity, PCWUK top-3 personal lines with esure
Ageas UK homeBuildings and contentsRetailBrokers, affinity—
esure (brand)Digital-first motor and home insurerPrice-sensitive digital retailDirect, PCWFounded 2000; >2.1m policies at acquisition
Sheilas' WheelsMotor/home brand historically targeted at women driversRetailDirect, PCWPart of esure
First AlternativeSpecialist motor/home brandRetailDirect/PCWPart of esure
Saga (affinity)Motor and home for over-50s, underwritten via AICL / Ageas under a 20-year agreement; ~1.2–1.4m Saga policies at signingOver-50sSaga Services Ltd (broker)GBP 80m upfront plus contingent payments up to GBP 30m (2026) and up to GBP 30m (2032)
Acromas Insurance Company Ltd (AICL)Gibraltar-registered underwriter, est. 2003——Acquired for ~GBP 67m
Embedded motor (BYD)Ageas UK is lead insurer for BYD's embedded insurance proposition in the UKEV buyersPoint of sale—
Embedded motor (Wrisk)Embedded motor delivered with WriskOEM/fleet partnersDigital API—

Management ambition: combined UK top-line of GBP 3.25bn by 2028 (Insurance Times). Annual cost synergies above GBP 100m, raised to above GBP 130m at the 8 Oct 2026 investor update (Quartr summary).

Europe — Portugal

Product line / brandDescriptionNotes
Ageas Portugal (Ageas Seguros)Multi-line Life and Non-Life via agents and brokersBuilt on the 2016 AXA Portugal acquisition
MédisHealth insurance brandBrand ownership per company materials
OcidentalBancassurance with Millennium bcp—
Seguro DirectoDirect motor/homeNot re-verified in this research

H1 2026 Portugal was hit by adverse weather (storms), as was Belgium.

Europe — Türkiye (JVs with Sabancı)

EntityLineNotes
AgeSALife and private pensionsExcellent FY2025 Life performance in Türkiye drove Europe Life NOR +20%
AksigortaNon-LifeHyperinflation accounting affects results

Asia

EntityCountryAgeas stakeLineNotes
Taiping LifeChina24.9%Life (agency, bancassurance)~230,000 agents, 15m customers, access to 70,000 bank branches (Ageas newsroom, 2026)
Taiping Pension (TPP)China10% (completed 24 Mar 2026)Pensions, employee benefitsTop-5 player; EUR 71bn pension AUM (2023); option to rise to 24.99% within three years (Caixin)
Taiping Asset ManagementChina20%Asset managementRanked 6th among insurance asset managers, ~EUR 200bn AUM (Ageas)
Taiping ReinsuranceHong Kong/China25%Reinsurance—
Ageas Federal LifeIndia74%Life (term, annuity, savings)Targets 3x premium growth by FY28 (CEO Jude Gomes, Business Standard, Dec 2025); digital distribution partnership with an aggregator, May 2026
Royal Sundaram GeneralIndia40%Non-LifeWith Sundaram Finance
Muang Thai Life / Muang Thai InsuranceThailand—Life / Non-LifePartnership
MB Ageas LifeVietnam—LifeBancassurance with MB Bank
Philippines, Laos, Cambodia entities——Life / Non-LifeListed by Ageas/Fitch (14 Oct 2026) as markets of operation
Etiqa (MAHB)Malaysia / Singapore30.95% → 0% (sold 11 Sep 2026)Life, Non-Life, Takaful#1 Non-Life Takaful in Malaysia; exited

Reinsurance — Ageas Re

OfferingDescriptionNotes
Third-party P&C reinsurance protectionTreaty reinsurance for external cedentsInflows +52% in 2024 (second year); third-party inflows +49% in H1 2025
Life reinsuranceInward Life riskPart of the "overarching" reinsurance strategy
Internal reinsurance / quota shareGroup quota share on Belgian businessCentralises risk and capital

CEO of Ageas Re: Joachim Racz, reporting to MD Reinsurance & Investments Emmanuel Van Grimbergen (Reinsurance News, 2024).

Financial Narrative

Comparability warning. FY2021–FY2022 figures are under IFRS 4 (as originally reported). FY2023–FY2025 are under IFRS 17/9. "Revenue" below means gross inflows, the company's top-line KPI.

Income statement / top line

Sources: FY2021 press release (net result EUR 845m, DPS EUR 2.75); FY2022 press release (net result EUR 1,011m incl. EUR 140m RPN(i); inflows EUR 16.4bn; DPS EUR 3.00); FY2024 press release (FY2023/FY2024 inflows, net result, NOR, NOR EPS; DPS 3.50); dividend calendar (FY2023: interim EUR 1.50 Oct 2023 plus final EUR 1.75 Jun 2024 = EUR 3.25); FY2025 press release and 8 Oct 2026 corporate presentation (insurance result EUR 1,761m; EPS EUR 8.80; NOR EUR 1,655m; net result EUR 1,712m; DPS EUR 3.75).

The company's headline per-share KPI is NOR EPS, shown above. FY2025 EPS of EUR 8.80 is +30% YoY including the China one-off (Quartr summary of the 8 Oct 2026 corporate presentation).

Margins. Gross, operating and EBITDA margins are not meaningful for an insurer. A proxy "net margin" (net result / gross inflows) can be computed:

Inflow CAGR. FY2022 to FY2025 inflows rose from EUR 16.4bn to EUR 19.6bn, a 3-year CAGR of ~6.1% in reported terms. At constant FX the company reports +10% (FY2024) and +9% (FY2025).

Commentary.

Top line: Growth accelerated under Impact24 and Elevate27. FY2024 inflows grew +10% at constant FX and scope (excluding the exited French business): Life +9% to EUR 11.7bn and Non-Life +14% to EUR 6.8bn. FY2025 grew +9% at constant FX, with Life sales strong in every region and Ageas Re adding momentum. H1 2026 inflows rose +17% to EUR 12.1bn at constant FX, or +8% at constant scope, inflated by the extra 25% of AG and by esure/Saga.

Profit: NOR rose from EUR 1,166m (FY2023) to EUR 1,240m (FY2024), despite a higher effective tax rate, driven by a 25% rise in the Life insurance result. It then jumped to EUR 1,655m in FY2025. The FY2025 inflection is partly structural (Non-Life NOR +21% to EUR 548m; combined ratio 92.5%) and partly one-off: a ~EUR 300m deferred-tax benefit from a renewed tax basis in China. Underlying growth was ~9%.

2026: H1 2026 NOR was EUR 776m (+6%), with Life at EUR 629m (+17%) offsetting EUR 180m of weather losses. FY2026 guidance is now above EUR 1.95bn. This includes the ~EUR 450m (realised: EUR 464m) MAHB capital gain and a ~EUR 30m lost MAHB contribution, so implied underlying NOR is roughly EUR 1.5bn+. The guidance was raised from "above EUR 1.5bn" given in February 2026.

Dividends: DPS has compounded from EUR 2.75 (FY2021) to EUR 3.75 (FY2025), a ~8.1% CAGR. A EUR 1.50 interim for FY2026 is due in December 2026. The Elevate27 commitment is +6% DPS per annum.

Balance sheet

Sources: FY2021 press release (Solvency II 197%); FY2022 press release (liquid assets EUR 0.6bn; Solvency II 218%); FY2024 press release (liquid assets EUR 1,066m; comprehensive equity EUR 16.1bn, EUR 88.14/share vs EUR 85.04 FY2023); FY2025 earnings call (comprehensive equity EUR 17.5bn; "current cash position" EUR 1.45bn, quoted at the Feb 2026 call).

Additional balance-sheet datapoints

Commentary. Under IFRS 17, comprehensive equity (shareholders' equity plus the net-of-tax CSM) is the best measure of the book. It grew from EUR 16.1bn to EUR 17.5bn in FY2025, helped by NOR and the esure-related capital increase, net of FX (TRY, CNY, INR weakness) and dividends. Solvency has been deliberately deployed: from ~218–219% in 2022–24, down to ~195% at H1 2026 after the AG step-up (EUR 1.9bn) and esure (EUR 1.51bn). Roughly +23pp has since been rebuilt through the MAHB sale. Implied post-MAHB solvency is ~218%, a simple sum not disclosed by the company. The group issued new Tier 2 and Restricted Tier 1 notes and a GBP senior note in 2025 (rating page), consistent with partial debt funding of esure and AG.

Cash flow and capital return

Sources: FY2022 press release (OFCG EUR 1,172m); FY2024 call (dividends received EUR 805m, +12% YoY, from which FY2023 ≈ EUR 719m is derived); FY2025 press release and call (cash upstream EUR 949m, +18%; HFCF EUR 774m); Aug 2024 announcement of a EUR 200m buyback. FY2026 cash upstream guidance is above EUR 1.4bn, +49% (H1 2026 release), up from EUR 1.2bn guided in February 2026.

Commentary. For Ageas, the relevant cash metric is upstream from operating entities to the holding. Upstream has compounded at ~7% p.a. over 2017–2025 (corporate presentation, 8 Oct 2026). It will step up sharply in 2026 to above EUR 1.4bn, helped by 100% AG ownership, esure and higher Asia remittances. The 2025–27 HFCF target has been raised twice, from above EUR 2.2bn to above EUR 2.3bn and then above EUR 2.6bn. The shareholder remuneration target has risen to above EUR 2.2bn.

Ratios

Payout is computed as DPS / NOR EPS. The FY2025 payout falls to ~43% because of the China one-off. On adjusted NOR of EUR 1,355m, the payout would be roughly 52–53%, an approximation based on the share count.

H1 2026 ROE on NOR was 15.8%. Current ratio, cash conversion cycle and EBITDA-based ratios are not applicable to an insurance balance sheet.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentWhat it containsOwnership / consolidation

Belgium

AG Insurance (Life: guaranteed and unit-linked savings, group pensions/employee benefits, health; Non-Life: motor, fire/home, liability, workers' compensation, SME) plus AG Real Estate

75% until 28 Apr 2026, 100% thereafter; fully consolidated

Europe

UK (Ageas UK, esure from 30 Sep 2025, AICL/Saga), Portugal (Ageas Portugal group), Türkiye (AgeSA Life & Pension, Aksigorta Non-Life — JVs with Sabancı)

UK and Portugal consolidated; Türkiye equity-accounted

Asia

China (Taiping Life 24.9%; Taiping Pension 10% from 2026), India (Ageas Federal Life 74%; Royal Sundaram General 40%), Thailand (Muang Thai), Vietnam, Philippines, Laos, Cambodia; Malaysia/Singapore (MAHB 30.95%) until 11 Sep 2026

Mostly non-consolidated (equity-accounted); stakes in Taiping AM (20%) and Taiping Re (25%) per Caixin, May 2024

Reinsurance

Ageas Re: third-party inward P&C and Life reinsurance plus internal reinsurance

Fully consolidated (part of ageas SA/NV)

General Account

Holding company: cash, debt, legacy items (e.g., the RPN(i) liability linked to BNP Paribas Fortis CASHES), group costs

Holding

Revenue by Segment

Segment (EUR Mn)FY2024FY2025

Belgium gross inflows

5,3315,615

Europe gross inflows

4,1634,404

Asia gross inflows

8,5998,699

Reinsurance 3rd-party inflows (derived residual)

396882

Group gross inflows

18,48919,600

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment by Segment NOR

Segment NOR (EUR Mn)FY2024FY2025

Belgium

468497

Europe

203241

Asia

527860

Reinsurance

164208

General Account (derived)

-122-151

Group Net Operating Result

1,2401,655

Profitability KPI

Profitability KPIFY2024FY2025H1 2025H1 2026

Group Non-Life combined ratio (%)

93.392.592.195.2

Belgium Life guaranteed margin (bps)

—10292—

Group ROE on NOR (%)

16.319.3—15.8

Business Lines

Line (EUR Mn)FY2022FY2024FY2025

Life gross inflows

11,30011,700—

Non-Life gross inflows

5,1006,800—

Life Net Operating Result

—9091,259

Non-Life Net Operating Result

—454548

Key Financials and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Gross inflows (EUR Mn)

—16,40017,11818,48919,600

Group insurance result (EUR Mn)

————1,761

Net Operating Result (EUR Mn)

——1,1661,2401,655

Net Operating Result ex-China one-off (EUR Mn)

——1,1661,2401,355

Net result attributable (EUR Mn)

8451,0119531,1181,712

Net Operating EPS (EUR)

——6.356.788.80

Gross dividend per share (EUR)

2.753.003.253.503.75

Margin Analysis (%)

Ratio (%)FY2022FY2023FY2024FY2025

Net result / gross inflows (%)

6.25.66.08.7

NOR / gross inflows (%)

—6.86.78.4

Combined ratio Non-Life (%)

——93.392.5

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Holding cash / General Account liquid assets (EUR Mn)

—600—1,0661,450

Comprehensive equity incl. CSM (EUR Mn)

———16,10017,500

Comprehensive equity per share (EUR)

——85.0488.14—

Solvency II ratio, year-end (%)

197218———

Datapoint Details

DatapointValueSource

Solvency II ratio, H1 2024

219%

H1 2024 press release

Pro-forma Solvency II ratio incl. esure and Saga (H1 2025)

205%

H1 2025 call

Solvency II ratio, H1 2026

195%

H1 2026 press release (impacted by the AG step-up, Taiping Pension, debt instruments and the Belgian sovereign downgrade)

MAHB sale impact on Solvency II

+23pp (completed Sep 2026; guided ~25pp in Aug 2026)

Ageas release, 11 Sep 2026

Neutral solvency level (management)

175%

H1 2025 call

Contractual Service Margin, H1 2026

EUR 11.1bn

H1 2026 press release

Life liabilities, H1 2026

EUR 117bn

H1 2026 press release

Pension assets under management incl. Taiping Pension share

EUR 17.4bn

H1 2026 press release

Enterprise value (aggregator)

EUR 21.13bn

GuruFocus

Cash Flow

MetricFY2022FY2023FY2024FY2025

Cash upstream from insurance entities (EUR Mn)

—719805949

Holding Free Cash Flow (EUR Mn)

———774

Operational free capital generation (EUR Mn)

1,172———

Share buyback announced (EUR Mn)

——200—

Returns & Leverage Ratios (%)

RatioFY2023FY2024FY2025

ROE on NOR (%)

—16.319.3

Dividend payout on NOR EPS (%)

515243

Revenue by Region

Region (EUR Mn)FY2024FY2025

Belgium

5,3315,615

Europe excl. Belgium (UK, Portugal, Türkiye)

4,1634,404

Asia

8,5998,699

Reinsurance 3rd party (global, derived)

396882

Growth (%)

Growth (%)FY2025 vs FY2024

Belgium (reported)

5.3

Europe (reported)

5.8

Asia (reported)

1.2

Group (constant FX)

9.0

Country Overview

CountryMetricPeriodValueSource

UK

Gross written premium (GBP M)

H1 2025 → H1 2026

726.3 → 1210

Insurance Times, 27 Aug 2026

Malaysia/Singapore (MAHB)

NOR (EUR M) / remitted (EUR M)

FY2025

64 / 21

Ageas, 3 Aug 2026

Belgium

Market share Life / Non-Life (%)

FY2025

28 / 17

Ageas corporate presentation, 8 Oct 2026

Belgium

Combined ratio before quota share (%)

FY2025

90.5

Same

China (Taiping Pension)

Pension AUM (EUR bn, 100%)

202371

Ageas, May 2024

Price Datapoint Details

Price datapoint (EUR unless noted)ValueDate / source

Latest price

71.73

9 Oct 2026 (Lang & Schwarz, via ad-hoc-news)

Price on MAHB completion day

75.10

11 Sep 2026 (Trivano)

52-week range

55.85–75.05

MarketScreener, Aug 2026

YTD 2026 change

+20.3%

MarketScreener, 21 Aug 2026

3-year low

35.66

MarketScreener

5-year low

33.70

MarketScreener

Share Price

MetricOct 2021Oct 2022Oct 2023Oct 2024Oct 2025Jul 2026

AGESY price (USD)

48.7934.5538.4652.1466.6781.38

Valuation Snapshot

MultipleValueSource / basis

P/E (FY2025 EPS EUR 8.80 at EUR 71.73)

8.2x

Computed

P/E 2026e (consensus)

9.36x

MarketScreener (Aug 2026)

P/E 2027e (consensus)

8.87–9.05x

MarketScreener

P/B

1.44–1.47x

GuruFocus

EV / Sales 2026e

1.13–1.15x

MarketScreener

Dividend yield (FY2025 DPS EUR 3.75 at EUR 71.73)

5.2%

Computed

Dividend yield 2026e / 2027e

5.5–5.6% / 5.9–6.0%

MarketScreener

Capital Markets

ItemValueSource

Coverage

~25–26 analysts

Simply Wall St

Consensus price target

~EUR 70 (Simply Wall St); USD 79.22 for the ADR (getquin)

Discrepancy across aggregators and dates

Notable recent actions

JPMorgan PT raised from EUR 70 to EUR 80 (5 Oct 2026); Berenberg PT raised, Buy (4 Aug 2026); AlphaValue/Baader "Add" (3 Aug 2026)

TipRanks / MT Newswires

Last half-year EPS vs consensus

EUR 3.94 vs EUR 3.67 (H1 2026, per TipRanks data)

TipRanks

Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Interim DPS (EUR)

——1.501.501.50

Final DPS (EUR)

——1.752.002.25

Total gross DPS (EUR)

2.753.003.253.503.75

Capital Programmes

ProgrammeSize (EUR Mn)AnnouncedStatus

Share buyback

200

Aug 2024 (H1 2024 results)

—

New buyback programmes 2025–26

Not announced

—

Capital prioritised for esure and AG. MAHB proceeds could fund future buybacks — unconfirmed.

Group Entities

EntityS&PMoody'sFitch

ageas SA/NV (IFS)

A+ / Stable (17 Apr 2025)

A1 / Stable (16 Oct 2024)

AA- / Stable (affirmed 14 Oct 2026)

AG Insurance (IFS)

A+ / Stable

A1 / Stable

AA- / Stable (affirmed 14 Oct 2026)

Ageas Insurance Ltd (UK) (IFS)

A+ / Stable

NR

AA- / Stable (affirmed 14 Oct 2026)

Ageas Insurance International

NR

NR

A+ / Stable (Oct 2025)

Issuer Details

IssuerInstrumentS&PMoody'sFitch

Ageasfinlux SA

FRESH grandfathered Restricted Tier 1 (2002), perpetual

A-

Baa2

BBB

AG Insurance

Fixed-rate reset dated subordinated Tier 2 (2015, due 2047)

A-

NR

A-

ageas SA/NV

Subordinated fixed-to-floating Tier 2 (2019)

A-

NR

A-

ageas SA/NV

Perpetual RT1, fixed-rate resettable, temporary write-down (2019)

BBB+

NR

BBB+

ageas SA/NV

Subordinated fixed-to-floating Tier 2 (2020, due Nov 2051)

A-

NR

A-

ageas SA/NV

Subordinated fixed-to-floating Tier 2 (2025)

A-

NR

A-

ageas SA/NV

Perpetual RT1 (2025)

BBB+

NR

BBB+

ageas SA/NV

GBP Senior Fixed Rate Notes (2025)

A+

A1

NR

Analyst Conclusions

Management guidance (latest)

ItemGuidance
FY2026 Net Operating Result>EUR 1.95bn, incl. ~EUR 450m MAHB gain (realised EUR 464m), less ~EUR 30m of lost MAHB contribution, assuming ~3pp weather on the combined ratio
FY2026 cash upstream>EUR 1.4bn (+49%)
FY2026 interim DPSEUR 1.50 (December 2026)
2025–27 average EPS growth6–8%
2027 EPSEUR 8.00–8.50, upper end expected
2025–27 HFCF>EUR 2.6bn
2025–27 shareholder remuneration>EUR 2.2bn; DPS +6% p.a.
Discounted combined ratio 2027~92% (excl. exceptional weather)
UK synergies>GBP 130m p.a.; full run-rate from 2028

Consensus growth expectations. Consensus P/E of 9.36x (2026e) and 8.87–9.05x (2027e) implies EPS growth of about 3–5% from 2026 to 2027 on a reported basis. 2026 is inflated by the MAHB gain, so the underlying growth expectation is higher.

Bull case

  1. Cash inflection. Upstream jumps from EUR 949m to above EUR 1.4bn in 2026. With 100% of AG, esure synergies arriving in 2027–28 and Asia remittances improving, cumulative HFCF above EUR 2.6bn could support dividend growth above 6% and/or renewed buybacks funded by the ~EUR 1.1bn MAHB proceeds.

  2. Underlying earnings compounding. Ex-one-offs, NOR grew about 9% in FY2025 and is guided at roughly EUR 1.5bn+ for 2026 despite EUR 180m of H1 weather. The 2027 EPS target sits at the upper end of EUR 8.00–8.50. On a ~EUR 72 share price, that is under 9x 2027 earnings with a ~5.5% yield.

  3. Value-realisation optionality. The MAHB sale at ~2x book and ~15x earnings shows the hidden value of Asian minorities carried on balance sheet. Similar dynamics (Taiping, India, Thailand) and a strategic reference shareholder (BNP) provide a valuation floor and potential re-rating.

Bear case

  1. Earnings quality. Headline NOR is flattered by one-offs: EUR 300m China tax in 2025 and EUR 464m disposal gain in 2026. Asia, the largest NOR segment (EUR 860m in FY2025), converts poorly into cash, and China's rate and regulatory environment remains volatile.

  2. UK integration and cycle. esure was bought near the peak of UK motor pricing. With the market softening (management, 2025), synergy delivery may only offset margin compression. Full financial contribution is not expected before 2028.

  3. Capital consumption and concentration. Solvency fell from ~219% to 195% before the MAHB rebuild. Weather and Belgian sovereign spread risk are concentrated, and BNP Paribas's ~24.1% stake may cap takeover premia while constraining strategic independence.

Key catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
Dec 2026Payment of the EUR 1.50 interim dividend
Q4 2026 – Q1 2027Decision on deploying MAHB proceeds (M&A vs buyback)
Jan 2027Reinsurance renewals (Ageas Re pricing and volume)
~24 Feb 2027FY2026 results: delivery vs >EUR 1.95bn NOR; FY2026 DPS (EUR 3.75 × 1.06 ≈ EUR 3.98 implied); FY2027 guidance
2,027esure integration milestones and synergy tracking (>GBP 130m)
1 Jan 2027Start of the renewed 15-year BNP Paribas Fortis bancassurance agreement
Within ~3 years of Mar 2026Possible exercise of the Taiping Pension step-up to 24.99%
OngoingBelgian and Portuguese weather; UK motor pricing; Chinese discount rates and tax; Belgian sovereign rating; any BNP Paribas stake movements
Late 2027Next strategic cycle (post-Elevate27) — likely a Capital Markets Day

Concluding analyst verdict

Ageas enters late 2026 materially reshaped. In eighteen months, management bought out BNP Paribas Fortis's 25% of AG Insurance, acquired esure and Saga's underwriter to build a top-three UK personal-lines platform, took a foothold in Chinese pensions, and sold its Malaysian minority at roughly twice book. Each move pushes the group from a holding of minority partnerships toward an owner-operator of consolidated, remittable earnings. That shift is the core of the investment case, and it is now visible in the numbers. Cash upstream is guided up 49% to above EUR 1.4bn in 2026, and the cumulative 2025–27 Holding Free Cash Flow target has risen to above EUR 2.6bn from above EUR 2.2bn at launch.

Operating fundamentals are sound. The Non-Life combined ratio held at 92–93% through 2024–25 and the Belgian Life guaranteed margin is above 100 bps, while the AA- Fitch rating was reaffirmed this month. The caveats are real. Reported profit in 2025 and 2026 is flattered by a EUR 300m China tax benefit and a EUR 464m disposal gain. Asia still generates far more accounting profit than cash, and UK motor is entering a softer phase just as esure integration peaks. Weather is now a recurring rather than exceptional drag.

On roughly 8–9x forward earnings and a dividend yield of about 5.5%, with DPS growth contractually framed at 6% a year, the market prices Ageas as a low-growth income stock. That stance seems to under-credit both the cash inflection and the latent value in its Asian stakes. The MAHB sale crystallised that value at ~15x earnings.

  • clean delivery of UK synergies;

  • disciplined redeployment of the MAHB proceeds;

  • continued conversion of Asian earnings into holding cash.

BNP Paribas's near-25% stake is best viewed as a stabilising anchor rather than an imminent bid catalyst.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleIn role sinceBackground / prior rolesEducationAge

Hans De Cuyper

CEO, Executive Director

Oct 2020

CEO AG Insurance; earlier CEO and CFO of Etiqa (Maybank Ageas JV), Malaysia

—

57 (MarketScreener)

Wim Guilliams

CFO, Executive Director

1 Jun 2023 (Deputy CFO from 1 Jan 2023)

CFO AG Insurance from 2015; previously executive and board roles at KBC Group (Belgium, CEE) and ING Insurance Belgium; led group IFRS 17 implementation

Master in Applied Economic Sciences (KU Leuven, 1994); post-graduate in financial risk management (Saint-Louis Brussels); MBA in Financial Services & Insurance

Born 1973

Christophe Vandeweghe

CRO, Executive Director

1 Jun 2024

CFO Ageas Portugal; CRO Continental Europe

——

Heidi Delobelle

Managing Director Belgium (CEO AG Insurance)

1 Jun 2024 (ExCo)

CEO AG Insurance

——

Ben Coumans

Managing Director Europe (UK, Portugal, Türkiye)

1 Jun 2024

Group Director Strategy and M&A; succeeded Antonio Cano

——

Filip Coremans

Managing Director Asia

—

Long-standing Ageas executive

——

Emmanuel Van Grimbergen

MD Reinsurance & Investments

1 Jun 2024

Group CRO before 2024

——

Karolien Gielen

Managing Director Business Development

2024———

“—” = not publicly disclosed.

Board of Directors by Director

DirectorRoleCommittee leadershipIndependence

Bart De Smet

Chairman (since 2020)

Chair, Nomination & Corporate Governance Committee

—

Yvonne Lang Ketterer

Vice-Chair

Chair, Risk & Capital Committee

Independent

Xavier de Walque

Director

Chair, Audit Committee (per Ageas leadership page)

Independent

Katleen Vandeweyer

Director

Chair, Remuneration Committee

Independent

Alicia García Herrero

Director

—

Independent

Carolin Gabor

Director

—

Independent

Jean-Michel Chatagny

Director

—

Independent

Françoise Lefèvre

Director

—

Independent (presumed)

Sonali Chandmal

Director

—

Independent (presumed)

Renaud Dumora

Director (appointed AGM 20 May 2026)

—

Non-independent; BNP Paribas nominee under the shareholder agreement

Hans De Cuyper

CEO

—

Executive

Wim Guilliams

CFO

—

Executive

Christophe Vandeweghe

CRO

—

Executive

Executive Leadership Team

NameRoleTotal compensation (EUR)

Hans De Cuyper

CEO

2,350,000

Wim Guilliams

CFO

1,350,000

Christophe Vandeweghe

CRO

1,270,000

Bart De Smet

Non-executive Chair

185,000

Independent non-executives (range)

Directors

92000–120500

Board & Management Changes

DateChange

1 Jan 2023 / 1 Jun 2023

Wim Guilliams Deputy CFO, then CFO; Christophe Boizard retires after 11+ years

15 May 2024 AGM / 1 Jun 2024

ExCo enlarged to eight; Vandeweghe CRO; Van Grimbergen MD Reinsurance & Investments; Delobelle MD Belgium; Coumans MD Europe (replacing Antonio Cano); Gielen joins

30 Sep 2025

esure leadership change on completion

20 May 2026 AGM

Renaud Dumora (BNP Paribas nominee) appointed non-executive director

Major Shareholders

HolderStake (% of shares)Notes / date

BNP Paribas Cardif (BNP Paribas Group)

22.5

After the EUR 1.1bn capital contribution at EUR 60/share; crossed 20% on 28 Apr 2026

BNP Paribas Fortis (BNP Group)

1.62

3,473,271 shares pledged to CASHES holders; voting suspended

Belgian State (SFPI/FPIM)

~6.0

Diluted from 6.3% by the BNP capital increase (Test-Aankoop, Dec 2025)

Free float

~65.3

MarketScreener

Insiders (directors and officers)

<1 (individual holdings not disclosed in sources reviewed)

—

Competitive Landscape

Competitors by Segment

SegmentCompetitor—

Belgium

KBC Insurance (KBC Group)

Bancassurance rival; KBC's integrated bank-insurer model competes directly with the AG–BNP Paribas Fortis channel

Belgium

Belfius Insurance

State-owned bank-insurer; strong in retail and public sector

Belgium

Ethias

Mutual-origin insurer; strong in public sector and retail

Belgium

AXA Belgium

Major broker-channel competitor in P&C

Belgium

Allianz Benelux; NN Belgium; P&V/Vivium; Baloise Belgium

Broker and life competitors; AG remains #1 with 28% Life / 17% Non-Life share

UK personal lines

Aviva (incl. Direct Line after its 2025 acquisition)

Largest UK personal-lines player; Ageas competed for Direct Line in 2024

UK personal lines

Admiral Group

Leading PCW/direct motor insurer; benchmark for digital efficiency

UK personal lines

Hastings Direct

PCW-focused motor/home competitor

UK personal lines

LV= / Allianz UK; AXA UK; Zurich UK; RSA (Intact)

Broker and affinity competition

Portugal

Fidelidade; Generali Tranquilidade; Allianz Portugal

Ageas is #2 by premiums (post-2016)

Türkiye

Allianz Sigorta; Anadolu Sigorta; other bank-owned insurers

—

China

Ping An; China Life; CPIC; New China Life

Taiping Life is a significant but non-top-3 player

India

LIC; SBI Life; HDFC Life; ICICI Prudential

Ageas Federal Life is a small private player targeting 3x growth

Reinsurance

Munich Re; Swiss Re; Hannover Re; SCOR

Ageas Re is a sub-scale niche entrant

European multi-line peers (investor benchmark)

NN Group; ASR Nederland; Aegon; Baloise/Helvetia; Generali; AXA

Valuation and capital-return comparables

Competitor Detail

Metric (FY2025)Ageas

Gross inflows / premiums (EUR Bn)

19.6

Top-line growth, constant FX (%)

9

Operating ROE (%)

19.3

Non-Life combined ratio (%)

92.5

Forward P/E 2026e (x)

9.4

Recent Developments

*Layoffs / hiring. esure/Ageas UK integration synergies above GBP 130m imply cost and headcount actions in the UK, but specifics are not publicly disclosed.

*Litigation and regulatory actions.

Company Snapshot

53,000

Employees

1824

Founded

Brussels, Belgium

Headquarters

SWOT Analysis

Strengths

  • Belgian leadership. AG holds ~28% Life and ~17% Non-Life share (FY2025) and has been 100% owned since 28 Apr 2026, lifting Ageas's share of Belgian cash upstream from 75% to 100%.
  • Earnings momentum. NOR rose from EUR 1,166m (FY2023) to EUR 1,240m (FY2024) to EUR 1,655m (FY2025), about +9% underlying in FY2025. H1 2026 NOR was +6% despite EUR 180m of weather.
  • Underwriting quality. The Non-Life combined ratio was 93.3% (FY2024) and 92.5% (FY2025); the Belgian combined ratio was 90.5% before quota share (FY2025).
  • Capital and ratings. Solvency II was 195% at H1 2026, before +23pp from the MAHB sale. Ratings are S&P A+, Moody's A1 and Fitch AA-, all Stable; Fitch affirmed on 14 Oct 2026.
  • Cash generation. Upstream rose from EUR 805m (FY2024) to EUR 949m (FY2025) and is guided above EUR 1.4bn for FY2026. The HFCF target was raised to above EUR 2.6bn.
  • Progressive dividend. DPS grew from EUR 2.75 (FY2021) to EUR 3.75 (FY2025), an ~8% CAGR, with +6% p.a. committed.
  • Locked-in distribution. The BNP Paribas Fortis bancassurance agreement is renewed for 15 years from 2027, and the Saga affinity deal runs 20 years.

Weaknesses

  • Asian cash conversion. MAHB remitted EUR 21m against EUR 64m NOR (2025). Asia contributed EUR 860m NOR in FY2025, but the group's total upstream was only EUR 949m.
  • Earnings quality noise. FY2025 NOR included a ~EUR 300m one-off China deferred-tax benefit, and FY2026 includes a EUR 464m disposal gain. Both complicate the underlying trend.
  • Weather sensitivity. The H1 2026 combined ratio was 95.2% vs 92.1% a year earlier, on EUR 180m of weather claims in Belgium and Portugal.
  • Solvency drawdown. The ratio fell from 219% (H1 2024) to 195% (H1 2026) after the acquisitions; it was also hit by the Belgian sovereign downgrade.
  • Share dilution. About 11m new shares were issued in 2025 for esure, and ~18m in 2026 to BNP at EUR 60, below the current ~EUR 72 share price.
  • Limited disclosure on non-insurance metrics. The group discloses no group debt maturity ladder in summary releases, and segment revenue for minority partnerships is reported only at Ageas share.

Opportunities

  • esure synergies. Synergies above GBP 130m p.a. (raised Oct 2026), ROI above 12%, and HFCF/share ~10% accretive after 2027, with full contribution from 2028.
  • Redeployment of MAHB proceeds. About EUR 1.1bn of cash proceeds plus solvency headroom are available for bolt-ons in Europe or Asia, or for buybacks.
  • Chinese pensions. The Taiping Pension option to go to 24.99% within three years; TPP managed EUR 71bn of pension AUM in 2023.
  • Ageing-society propositions. Target of more than EUR 2bn of additional Life and Pension liabilities by 2027, on track to exceed.
  • Reinsurance growth. Third-party inflows grew +52% (2024) and +49% (H1 2025); Reinsurance NOR rose from EUR 164m to EUR 208m in FY2025.
  • AI-driven efficiency. More than 300 use cases are deployed, 35% targeting claims and fraud — a direct lever on the combined ratio.
  • India. Ageas Federal Life targets 3x premium by FY28.

Threats

  • UK pricing cycle. Management flagged a softer UK market in 2025, just as the integration of the GBP 1.295bn esure deal runs.
  • Climate and nat-cat in Belgium and Portugal. Shown by H1 2026; FY2026 guidance already assumes ~3pp of weather on the combined ratio.
  • China macro and regulatory risk. Falling yields hit FY2022 by ~EUR 100m in H1 alone, and the tax regime changed in 2025.
  • FX. TRY, CNY, INR and GBP translation; FX volatility partly offset comprehensive equity growth in FY2025.
  • Shareholder concentration. BNP Paribas holds ~24.1% economic interest; strategic divergence or takeover speculation could shape outcomes.
  • Belgian sovereign credit and Solvency II spread risk. The downgrade impact is cited in the H1 2026 solvency walk.
  • Regulatory change. The Solvency II review, Belgian tax on insurance and savings products, and UK FCA pricing rules.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025Agreement to acquire esure from Bain Capital for GBP 1.295bnLargest acquisition of the Elevate27 cycle; UK top-3
Apr–May 2025~EUR 550m accelerated bookbuild (~11m new shares)Part-funds esure; dilution offset by 6–8% EPS growth commitment
17 Apr 2025S&P affirms A+/Stable (rating page date)Ratings resilience through the acquisitions
21 May 2025AGM/EGMFY2024 dividend (EUR 3.50) approved
4 Jun 2025Ex-date of FY2024 final dividend, EUR 2.00Shareholder return
2025Completion of AICL (Saga underwriting) acquisition, ~GBP 67mFirst milestone of the 20-year Saga partnership
27 Aug 2025H1 2025: inflows EUR 10.5bn (+4%), NOR EUR 734m (+20%), combined ratio 92.1%; FY2025 guidance raised to EUR 1.30–1.35bn; HFCF target to >EUR 2.3bnFirst Elevate27 target upgrade
30 Sep 2025esure acquisition completed; esure CEO and CFO step downIntegration begins
20 Oct 2025Fitch affirms AA-/Stable (rating page date)Ratings affirmed post-esure
3 Dec 2025Ex-date of EUR 1.50 interim dividendInterim dividend policy maintained
7–8 Dec 2025Framework agreement with BNP Paribas: 25% of AG for EUR 1.9bn; EUR 1.1bn BNP Cardif equity at EUR 60; 15-year bancassurance renewalTransformational for the Belgian franchise and shareholder base
Jan 2026Second upgrade cycle
25 Feb 2026FY2025 results: inflows EUR 19.6bn (+9% cFX), NOR EUR 1.655bn (+33%), net result EUR 1.712bn, DPS EUR 3.75; FY2026 NOR guidance >EUR 1.5bnRecord year; includes ~EUR 300m China one-off
24 Mar 2026Completion of Taiping Pension 10% capital increase (RMB 1,075m)Entry into the Chinese pension market
28 Apr 2026Completion of AG Insurance 25% acquisition100% ownership of AG
29 Apr 2026Transparency notification: BNP Paribas crosses 20% (as of 28 Apr)Shareholder structure change
May 2026Ageas Federal Life digital distribution partnership with an insurance aggregatorIndia growth initiative
20 May 2026AGM: FY2025 dividend EUR 3.75 approved; Renaud Dumora (BNP nominee) appointed to the boardGovernance
3–5 Jun 2026FY2025 final dividend EUR 2.25: ex-date 3 Jun, paid 5 JunShareholder return
3 Aug 2026Agreement to sell 30.95% of MAHB to Maybank for EUR 1.1bnExit Malaysia/Singapore at ~2x book
4 Aug 2026Berenberg raises price target, keeps Buy (MT Newswires headline)Sell-side reaction
27 Aug 2026H1 2026: inflows EUR 12.1bn (+17% cFX), NOR EUR 776m (+6%), ROE 15.8%, Solvency II 195%, CSM EUR 11.1bn; weather impact EUR 180m; FY2026 NOR guidance raised to >EUR 1.95bn; cash upstream >EUR 1.4bnGuidance upgrade despite weather
1 Sep 2026Bank Negara Malaysia approves the MAHB transactionRegulatory clearance
8 Sep 2026Share purchase agreement signed with MaybankExecution
11 Sep 2026MAHB sale completed; EUR 464m net gain; +23pp Solvency IICapital flexibility
5 Oct 2026JPMorgan raises price target from EUR 70 to EUR 80 (TipRanks, via ad-hoc-news)Sell-side upgrade
8 Oct 2026Investor update and esure deep-dive (London): 2027 EPS target EUR 8.00–8.50 now expected at upper end; UK synergy target >GBP 130m; HFCF >EUR 2.6bn; remuneration >EUR 2.2bnThird effective upgrade of the cycle
14 Oct 2026Fitch affirms ageas SA/NV, AG Insurance and Ageas Insurance Ltd at AA-, StableCredit stability

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Revenue by Segment: Belgium gross inflows to Belgium: Belgium gross inflows rose from EUR 5,331 Mn in FY2024 to EUR 5,615 Mn in FY2025.
ageas SA/NV — Revenue by Segment: Belgium gross inflows to Belgium
Series (EUR Mn)FY2024FY2025
Belgium gross inflows5,3315,615
Europe gross inflows4,1634,404
Asia gross inflows8,5998,699
Reinsurance 3rd-party inflows ( residual)396882
Group gross inflows18,48919,600
Belgium468497

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Ageas press release, "Ageas reports first half-year results 2026" (27 Aug 2026) — ageas.com newsroom; via.ritzau.dk regulated file
  2. Ageas H1 2026 earnings call transcript (27 Aug 2026) — roic.ai
  3. Ageas press release, "Ageas reports full-year 2025 results" (25 Feb 2026); "Strong performance in a transformational year" — ageas.com
  4. Ageas FY2025 earnings call transcript (25 Feb 2026) — roic.ai / GuruFocus / StockAlarm
  5. Reinsurance News, FY2025 segment figures (25 Feb 2026): H1 2026 (27 Aug 2026); esure completion (30 Sep 2025) · Maybank sale (3 Aug 2026)
  6. Ageas press releases: "Ageas reports full-year results 2024"; "A strong financial and operational performance" (FY2024 key figures incl. FY2023)
  7. Ageas H1 2024 press release (28 Aug 2024): H1 2025 press release (27 Aug 2025)
  8. Ageas FY2022 press release (22 Feb 2023, Euronext): FY2021 press release (23 Feb 2022, Euronext)
  9. Ageas press releases: esure completion · Saga/AICL completion · Taiping Pension agreement (May 2024) and completion (24 Mar 2026) · MAHB completion (11 Sep 2026)
  10. Ageas / BNP Paribas releases on the AG Insurance 25% transaction (8 Dec 2025) and completion: Ageas–BNP transparency notifications (13 Aug 2024; 29 Apr 2026)
  11. Fitch affirmation release (GlobeNewswire, 14 Oct 2026)
  12. Ageas rating page (ageas.com/rating), ESG rating & benchmarks page, sustainability page, leadership page, CFO biography
  13. Quartr event summaries: Investor update and corporate presentation (8 Oct 2026) · MAHB status update (3 Aug 2026) · H2 2025 summary
  14. Insurance Times (H1 2026 UK GWP: Saga deal) · Insurance Business (esure · Maybank · FY2022) · Ageas UK press release (esure completion)
  15. The Star / NST / Business Today Malaysia (Maybank transaction, Aug–Sep 2026)
  16. Caixin Global (Taiping Pension, May 2024): Life Insurance International
  17. Test-Aankoop (Dec 2025 analysis of the BNP/AG deal): Dow Jones via iTiger (BNP stake, Feb 2025)
  18. MarketScreener, Simply Wall St, TipRanks, TradingView, GuruFocus, getquin, Digrin, ad-hoc-news (market data, consensus, governance and compensation aggregations — secondary; used only where primary data were unavailable)
  19. SustainabilityReports.com summaries of Ageas Annual Reports 2022–2024 (sustainability datapoints)
  20. Wikipedia entries for Ageas and Ageas Federal Life (historical context only)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.